NVIDIA (the company)'s holdings

Filed by NVIDIA

These are the company's own investments, not its chief executive's.

—1-year return (simulated)

September 30, 2025 to November 4, 2026・Covers 37% of the holdings' value

Less than 80% of the holdings could be priced, so no return is shown.

Photo: Jensen Huang, NVIDIA's chief executive; Peter Dasilva, CC BY 4.0, Wikimedia Commons (cropped)

How it is worked out

From the quarter's end a year ago, each quarter's 13F is held, weighted by value, to the next quarter's end; the latest one to the latest close. The quarters compound.
Long stocks and ETFs only: no options, bonds, cash, trades within a quarter or dividends; spin-offs are not adjusted for.
Quarter-end prices come from the 13F filings themselves (value ÷ shares); what they cannot tell (a holding sold, a split, a big move) is checked against Tiingo's closes, and the latest prices are Finnhub's.
Holdings with no price are left out and the rest re-weighted. Under 80% priced, or while holdings are still being checked, no figure is shown.
A simulation from public filings, not the investor's actual performance.

Holdings at the end of June 30, 2026. 13F filings are due 45 days after a quarter ends, so they are one to four months old.

This quarter's biggest moves

8 stocks worth US$63.4B, options excluded.

Stock	This quarter	Shares	Value	Weight
INTCINTEL CORP	Unchanged	214,776,632	US$30B	47.27%
SPCXSPACE EXPLORATION TECHN CORP	New	122,764,805	US$21B	33.06%
CRWVCOREWEAVE INC	Unchanged	47,213,353	US$4.7B	7.41%
COHRCOHERENT CORP	Unchanged	7,788,161	US$3.1B	4.84%
NOKNOKIA CORP	To be checked	166,389,351	US$2.2B	3.48%
SNPSSYNOPSYS INC	Unchanged	4,821,717	US$2.2B	3.39%
NBISNEBIUS GROUP N.V.	To be checked	1,190,476	US$328.8M	0.52%
GENBGENERATE BIOMEDICINES INC	Unchanged	833,325	US$14.1M	0.02%

Each quarter's original 13F filing (SEC).